Drug Penetration Into Lung Cavities Predicts Which Tuberculosis Regimens Can Be Shortened
A validated translational platform linking lesion drug penetration to Phase 3 trial outcomes offers a new way to design shorter ...
A validated translational platform linking lesion drug penetration to Phase 3 trial outcomes offers a new way to design shorter ...
The Bronchiectasis and NTM Association has announced an Externally-Led Patient-Focused Drug Development meeting for non-cystic fibrosis bronchiectasis, proposed for late ...
An international expert workshop has prioritised targets and trial designs to break the three-decade therapeutic stalemate in desmoplastic small round ...
An international research team has shown that rings of extrachromosomal DNA lose their cancer-driving activity when trapped in micronuclei, a ...
Springer Nature's 2026 Editor of Distinction Awards recognise seventeen editors of BMC Pharmacology and Toxicology for safeguarding peer review quality ...
A co-led Buck Institute and Georgetown University team has won an ARPA-H award of up to $51.7 million to predict ...
Researchers have discovered that the protein HERC4 acts as the critical molecular switch that converts TNF survival signalling into cell ...
A new American College of Neuropsychopharmacology position paper co-led by UCLA Health lays out a roadmap for using biomarkers to ...
Researchers at Lund University have shown that precision-cut slices of bladder tumors keep their immune cells alive and functional for ...
Peter Barton Hutt, the former FDA Chief Counsel and longtime Critical Path Institute board member who shaped modern food and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine